Epigenetic processes that regulate gene expression, such as DNA methylation (DNAm), have been linked to individual differences in physical aggression. Yet, it is currently unclear whether:
| INTRODUCTION
Physical aggression is a highly conserved trait across many species that serves adaptive functions for promoting fitness (Nelson & Trainor, 2007) .
In humans, however, chronic physical aggression (e.g., physically destructive, violent and injurious behavior) is a hallmark of several psychiatric disorders, and accounts for significant morbidity, mortality, and societal cost worldwide (Waters et al., 2004) . Physical aggression features as a diagnostic criterion for conduct disorder (CD), intermittent explosive disorder (IED), and antisocial personality disorder (ASPD) based on the DSM-5 (APA, 2013) . Furthermore, physically aggressive behavior is overrepresented in individuals affected by other psychiatric disorders, such as autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), substance use disorders, and schizophrenia (e.g., Hamshere et al., 2013; Krueger, Markon, Patrick, Benning, & Kramer, 2007; Manchia & Fanos, 2017) . Importantly, longitudinal studies indicate that chronic physical aggression in childhood and adolescence predicts a wide range of maladaptive outcomes in adulthood (Kim-Cohen et al., 2005) .
Together, this evidence points to physical aggression as a behavioral risk marker for broader psychopathology (Sanislow et al., 2010) .
Research to date suggests that individual differences in physical aggression levels stem from the complex interplay of genetic and environmental influences. Twin and adoption studies have found that around half of the variance in physical aggression is attributable to genetic factors (Tuvblad & Baker, 2011 )-with higher heritability estimates observed for physical aggression that is severe, chronic, and pervasive across settings (Waltes, Chiocchetti, & Freitag, 2015) . Consistent with these findings, molecular genetic studies have reported associations between common genetic polymorphisms and physically aggressive behavior, focusing mainly on candidate genes involved in dopaminergic and serotonergic neurotransmission (esp. MAOA, COMT, 5HTT, and DRD4; Fernàndez- Pingault et al., 2013) as well as hormonal regulation (e.g., AR, OXTR, AVP; Veroude et al., 2016) . While only suggestive associations with individual single nucleotide polymorphisms (SNPs) have been identified by genome-wide studies, total SNP heritability has been found to account for substantial variance in aggressive behavior (measured globally), providing further evidence for genetic effects (10-54% across different population-based cohorts; Pappa et al., 2016) . In addition to genetic predispositions, epidemiological and clinical studies have identified numerous environmental risk factors for pathological physical aggression, including childhood abuse and neglect, family dysfunction, low socioeconomic status, and violence exposure (Chistiakov & Chekhonin, 2017) . Together, these factors are thought to co-act with genetic vulnerabilities to modulate propensity for physical aggression (Tremblay, 2015) . At present, however, little is known about the biological mechanisms through which these genetic and environmental inputs become translated into phenotypic variation.
In recent years, epigenetic processes that regulate gene expression, such as DNA methylation (DNAm), have emerged as a potential mechanism of interest. DNAm modulates transcriptional activity via the addition of a methyl group to DNA base pairs, primarily in the context of cytosine-guanine (CpG) dinucleotides (Jaenisch & Bird, 2003) .
Studies have shown that DNAm patterns are: (a) under significant genetic control-as evidenced by the discovery of a large number of methylation quantitative trait loci (mQTLs; Gaunt et al., 2016); sensitive to environmental signals, including nutritional, chemical, physical, and psychosocial exposures occurring in utero and beyond (Szyf & Bick, 2013) . In turn, DNAm patterns have been shown to associate with a broad range of psychiatric, physical, and behavioral phenotypes, including externalizing spectrum symptoms such as conduct problems, ADHD, and substance use (Barker, Walton, & Cecil, 2018; . Consequently, DNAm shows promise as a mechanism through which genetic and environmental factors interface, shaping trajectories of neurodevelopment, health, and behavior across the lifespan (Tremblay & Szyf, 2010) .
Thus far, only a handful of studies in humans have examined DNAm patterns associated with physical aggression. These studies were mainly based on data from young adults (DNA extracted from white blood cells at age 26-28 years), who were recruited as part of the Montreal Longitudinal and Experimental Study (MLES; Boisjoli, Vitaro, Lacourse, Barker, & Tremblay, 2007) and the Quebec Longitudinal Study of Kindergarten Children (QLSKC; Rouquette et al., 2014) and who were classified as following either a chronic versus low trajectory of physical aggression during childhood (ages 6-15 years; Broidy et al., 2003) . Using both targeted gene (Provençal, Suderman, Caramaschi, et al., 2013; Wang, Szyf, et al., 2012) and epigenome-wide Provençal et al., 2014) approaches, these studies have reported group differences in DNAm across a large number of gene promoters. Of interest, several of these genes related to biological processes that have been previously implicated in physical aggression, including monoamine neurotransmission, neuroendocrine function, and inflammatory response (Provençal, Booij, & Tremblay, 2015) . Besides this sample, one other study (van Dongen et al., 2015) based on a general population sample of over 2,000 adult twins examined epigenome-wide associations between DNAm (extracted from whole blood at mean age = 36.4 years) and a global measure of aggressive behavior (i.e., not specifically related to physical aggression, but also including social and verbal aggression). None of the DNAm sites were found to associate with aggressive behavior after multiple correction, which the authors suggested may have been due to low rates of more severe forms of aggression (i.e., physical aggression). However, a gene ontology analysis identified significant enrichment for genes involved in a range of central nervous system processes. As would be expected for brain-based phenotypes, epigenetic alterations in genes involved in neural function have also been observed in psychiatric disorders that feature aggression as a diagnostic criterion, such as childhood disruptive behavior disorders Cecil et al., 2017) , IED (Montalvo-Ortiz, Zhang, Chen, Liu, & Coccaro, 2018) , and ASPD (Beach, Brody, Todorov, Gunter, & Philibert, 2011; Checknita et al., 2015) .
Despite these promising findings, research on DNAm and physical aggression in humans has been limited in a number of important ways.
One first limitation relates to comorbidity. Individuals with high physical aggression often present with elevated symptomatology across a range of psychiatric and behavioral domains, such as hyperactivity, callousunemotional (CU) traits, emotional problems, and substance use, which have also been associated with altered DNAm patterns (Barker et al., 2018) . Because these are not typically examined in the extant literature, however, it remains unclear whether the identified DNAm patterns may be unique to physical aggression, shared with-or confounded by-other symptom domains. Relatedly, little is known about the extent to which these epigenetic patterns may reflect environmental risk factors for physical aggression (rather than aggression per se), such as childhood maltreatment and deprivation. Examining these associations is crucial to characterize more precisely the epigenetic "signature" of physically aggressive behavior, and its relationship to other common correlates ofand risk factors for-physical aggression.
A second limitation in the extant literature relates to tissue specificity. To date, studies on physical aggression in humans have been based entirely on DNA extracted from blood cells, as it is not possible to measure in vivo DNAm levels directly from the brain. This is problematic, given that DNAm patterns can vary substantially between tissues and cell-types . As such, it remains unclear to what extent DNAm patterns associated with physical aggression in blood may reflect those in the brain-likely the most relevant organ for the study of aggressive behavior (Bakulski, Halladay, Hu, Mill, & Fallin, 2016) . Establishing peripheral-central nervous system (CNS) concordance in DNAm is all the more important given that existing findings in blood point to the involvement of neural-related genes.
Furthermore, no study to date has examined associations between physical aggression and DNAm in buccal cells, another easily accessible peripheral tissue that has recently been found to correlate more strongly with brain tissue than blood . To this end, cross-tissue designs are necessary to gauge the utility of peripheral DNAm as a potential marker of brain-based behavioral phenotypes, such as physical aggression (Bakulski et al., 2016) .
Finally, there has been a paucity of investigation regarding the potential mechanistic role of peripheral DNAm in physical aggression.
In other words, based on associations alone, it is not currently possible to establish whether DNAm acts as causal or noncausal marker of physical aggression. Addressing this question bears important implications for informing research and clinical practice. On the one hand, DNAm marks need not to exert a causal influence to show potential utility as biomarkers-so long as they are robustly and reliably associated with a phenotype of interest. This is well exemplified in oncology, where noncausal DNAm patterns are already being used in the clinic as biomarkers for cancer detection, prognosis, and even treatment response (Ladd-Acosta & Fallin, 2016) . In the case of physical aggression, noncausal biomarkers could show utility in a number of different ways. First, noncausal biomarkers that reliably index increased risk for developing pathological aggression may be used, for example, to build more accurate predictive models. In turn, such models may help early detection and prevention via allocation of resources toward improvement of risk trajectories (e.g., preventive interventions to enhance mental health, social communication, emotional and behavioral regulation, etc.). Second, noncausal biomarkers that are associated with response to treatment for pathological aggression (e.g., anger management, dialectical behavior therapy, etc.), may help to inform decisions about treatment formulation. On the other hand, a causal effect is important to shed light on etiological pathways and to identify promising intervention targets. Indeed, interventions designed to modify DNAm marks (e.g., via pharmacological treatment) will be unlikely to have an effect on physical aggression unless these DNAm marks lie along the causal pathway (Szyf, 2015) . Advanced inference methods, such as Mendelian randomization (MR), represent one important tool for testing causality. MR involves the use of genetic information to minimize confounding common in observational research and strengthen causal inference about the effect of an exposure on an outcome (Davey Smith & Hemani, 2014) . While this method has been previously adapted to epigenetic markers (Caramaschi et al., 2017; Relton & Davey Smith, 2012; Richardson et al., 2018) and utilized to examine causality between peripheral biomarkers and a range of psychiatric outcomes (Prins et al., 2016; Pingault, Cecil, Murray, Munafo, & Viding, 2016; ) , it has yet to be utilized to clarify the nature of the observed relationship between DNAm and physical aggression.
| THE PRESENT STUDY
In light of the aforementioned gaps in the literature, the present study had three main aims. First, we used a hypothesis-free, genome-wide approach to examine DNAm patterns (DNA extracted from buccal swabs) associated with physically aggressive behavior, measured as engagement in physical fights over the past year, based on data from a community sample of high-risk youth. Second, we sought to comprehensively characterize the properties of aggression-associated DNAm patterns, including: (a) unique versus shared associations with commonly cooccurring psychiatric and behavioral symptoms; (b) relation to genetic and environmental factors; (c) cross-tissue concordance with blood and brain using publicly available resources (Edgar, Jones, Meaney, Turecki, & Kobor, 2017; Hannon, Lunnon, Schalkwyk, & Mill, 2015; Smith et al., 2015) ; and, (d) independent replication in adults with a chronic versus low history of physical aggression-the sample upon which most epigenetic studies of aggression to date have been based Provençal et al., 2014) . We considered DNAm loci to be potential biomarkers if they showed associations with physical aggression that were replicable and robust to multiple sensitivity analyses, based on the broad definition of a biomarker as "a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathologic processes or biological responses to a therapeutic intervention" (Biomarkers Definitions Working Group, 2001 ). Finally, we explored the causal nature of the identified associations using MR based on GWAS data from the Early Genetics and Lifecourse Epidemiology consortium (EAGLE; Pappa et al., 2016) , to provide preliminary data as to the potential role of DNAm patterns as a causal versus noncausal biomarker of physical aggression. Given the lack of prior evidence in this area, we did not have a priori hypotheses about causality in the association between peripheral DNAm and physical aggression. As such, our application of MR was guided by the epigenome-wide association analysis and should be considered as hypothesis-generating (Evans & Davey Smith, 2015) .
| MATERIALS AND METHODS

| Participants
The current sample was recruited as part of a larger cross-sectional study examining the influence of early adversity on youth outcomes (n = 204, age range = 16-24 years). Youth from deprived areas of London were recruited through multiple channels including inner-city colleges, internet websites, and a charity providing services to vulnerable youth, typically via self-referral. The study was carried out in accordance with the latest version of the Declaration of Helsinki. All procedures were approved by the UCL Research Ethics Committee (ID No: 2462/001) and participants provided informed consent prior to participation, after the nature of the procedures had been fully explained. Full details of the sample and study procedures are available elsewhere Cecil, Viding, Barker, Guiney, & McCrory, 2014 ).
The present analyses only included participants with complete data on DNAm and self-report engagement in physical fights (n = 119). This subsample was 53% female, ethnically diverse (49% White, 33% Black, 12% Other, 6% Asian) and at high-risk of adversity, with 68% of youth reporting experiences of childhood maltreatment.
This subsample was comparable to the full sample in terms of sociodemographic characteristics and exposure to adversity. In addition to self-report measures, informant reports were available for 80% of the subsample (n = 95), whereby an external informant (schools: teacher; charity: key worker) who knew each participant well completed a questionnaire booklet about the young person's emotional and behavioral function.
3.2 | Measures 3.2.1 | DNA methylation DNA was extracted from buccal swabs (representing a mixture of buccal epithelial cells and leukocytes) using procedures described in Freeman et al. (2003) . About 500 ng of high molecular weight DNA was subjected to sodium bisulfite conversion using the EZ-DNA methylation kit (Zymo Research, Orange, CA) using the manufacturers standard protocol. DNAm was quantified using the Illumina HumanMethylation450 BeadChip (Illumina) with arrays scanned using an Illumina iScan (software version 3.3.28). Samples were run in a single batch (i.e., bisulfite treatment and processing run at the same time across two plates side by side). To account for potential chip and position effects, we randomized sample chip allocation and placement on the chip. Furthermore, surrogate variable analysis was applied as a sensitivity step to minimize the influence of unmeasured sources of confounding (see Section 4). Initial data quality control was conducted using GenomeStudio (version 2011.1) to determine the status of staining, extension, hybridization, target removal, bisulfite conversion, specificity, nonpolymorphic, and negative controls. Probes that survived this stage were checked for concordance between their reported and predicted sex and then quantile normalised using the dasen function within the waterRmelon package (waterRmelon_1.0.3; Pidsley et al., 2013) in R. Probes were removed if they were crossreactive, polymorphic, used for sample identification on the array, had a SNP at the single base extension with a minor allele frequency larger than 5% (i.e., common polymorphisms; Chen et al., 2013; Price et al., 2013) , leaving a total of 413,510 probes in our sample. DNAm levels are indexed by beta values (ratio of methylated signal divided by the sum of the methylated and unmethylated signal, M/M+U).
| Engagement in physical fights
Engagement in physical fights was assessed via a self-reported item adapted from the Youth Risk Behavior Survey (Eaton et al., 2008) . The item specifically asked about the frequency of being in physical fights over the past year ("During the past 12 months, how many times were you in a physical fight?"). The item was rated on a 4-point scale, with 0 = "0 times," 1 = "1 time," 2 = "2-5 times," and 3 = "5+ times."
| Environmental risks
Childhood maltreatment was measured using the total score of the 28-item, self-report Childhood Trauma Questionnaire (Bernstein & Fink, 1998 ; α = 0.84), which assesses experiences of abuse and neglect "while growing up." Community violence exposure (CVE) over the past year was measured using the self-report Children's Report of Exposure to Violence (CREV; Cooley, Turner, & Beidel, 1995) . The 
| Psychiatric and behavioral correlates of physical aggression
We assessed multiple domains of individual functioning that have previously been associated with physical aggression. Self-reported substance use was measured via the Alcohol Use Disorders Identification Test (AUDIT; Saunders, Aasland, Babor, de la Fuente, & Grant, 1993) and the Drug Use Disorders Identification Test (DUDIT; Berman, 
| Data analysis
All analyses were performed in R (version 3.0.1), controlling for sex, age, and self-reported ethnicity (coded as a dummy variable) to account for potential confounding effects (Liang & Cookson, 2014) .
The analysis proceeded in three steps:
3.3.1 | Step 1: Are DNAm patterns in buccal cells associated with engagement in physical fights in a sample of high-risk youth?
We addressed this question using both probe-and region-level analyses. In probe-level analyses, we ran an epigenome-wide association analysis (EWAS) using the IMA package (Wang, Yan, et al., 2012) to identify differentially methylated probes (DMPs). DMPs were considered to be genome-wide significant if they passed a false discovery rate (FDR) correction of q ≤ 0.05. To identify enriched biological pathways, DMPs with a p ≤ .001 were analyzed further using an optimized gene ontology (GO) method that corrects for multiple potential confounds, including background probe distribution and gene size (for a full description, please refer to the Supporting Information Methods).
As a complement to the probe-level analysis, we also used two inde- (Hannon et al., 2015; Smith et al., 2015) . Further details regarding these cross-tissue resources are provided in Section 4 below.
|
Step 2: Are these markers differentially methylated in blood samples drawn from young adults with a history of chronic versus low physical aggression?
Next, we examined whether the DNAm markers that met genomewide significance in Step 1 were differentially methylated in peripheral leukocytes drawn from an independent sample of 38 young adults . Participants were identified as either following a chronic (CPA; n = 13; 38% female) or low (LPA; n = 25; 54% female) trajectory of physical aggression during childhood, based on prospective, longitudinal data (Broidy et al., 2003) . DNAm from peripheral T cells was extracted at ages 26-28 years and quantified using the Illumina 450k array. Due to the low volume of available DNA for Illumina 450k quantification, the 38 samples were originally pooled into 12 samples. Each sample comprised the same amount of DNA from 2 to 4 individuals of the same sex creating six samples for the CPA group (three pools for men CPA and three pools for women CPA) and six samples for the LPA group (three pools for men LPA and three pools for women LPA). For full details about the sample as well as the processing of the DNAm data, see . All participants were of Caucasian ethnicity and both groups were matched for sex; consequently, ethnicity and sex were not included as covariates.
In the analyses, group differences in DNAm were tested using linear regression models, correcting for age. All regressions were bootstrapped 10,000 times (boot package), and bias-corrected 95% confidence intervals (CI) were derived using the adjusted bootstrap percentile method (BCa; boot.ci function). Rather than evaluating replication based on FDR-corrected p-values-which can be unreliable in small samples due to bias in the estimates and standard errors-we used multiple other indicators that are less sensitive to sample size, namely the direction and magnitude of effects as well as the biascorrected bootstrapped 95% CIs. Bootstrapping is a nonparametric resampling simulation method that enables to address some of the issues of asymptotic inference by performing bias-adjustment and controlling for the proportion of Type I errors based on the empirical distribution of the data (Pace, 2012) . Associations with bootstrapped
CIs that did not cross zero were considered significant.
Step 3: Do these associations potentially reflect causal pathways?
As a final step, we tested the potential causal effect of the identified DNAm markers on aggressive behavior using MR. MR is a technique that uses genetic variants as robust instrumental variables, to strengthen causal inferences about the effect of an exposure on an outcome while minimizing potential confounding (Pingault et al., 2016) . The results of the probe-level EWAS are depicted in Table 1 . Overall, inspection of the Q-Q plot indicated little evidence of inflation (Supporting Information Figure S1 ), which was confirmed using the Bayesian method in the Bacon R package (van Iterson, van Zwet, & Heijmans, 2017; Supporting Information Figure S2 ). Four DMPs were found to meet a genome-wide threshold of significance (q ≤ .05; bolded in Table 1 ; see Supporting Information Figure S1 for the Table 1 are suggestive DMPs that did not meet genome-wide correction (q > .05). Of interest, five of these were located in the gene body of the dopamine receptor gene DRD4, one of the most extensively studied candidate genes for physical aggression and related externalizing problems . Furthermore, a number of additional DMPs were annotated to neurotransmitter and neuroendocrine genes, including other dopaminergic (COMT), serotonergic (GPM6B), glucocorticoid (SGK1), and thyroid hormone (TXNRD2, TNX2, FDX1) pathway genes. More broadly, our GO analysis indicated enrichment for a range of biological processes, including axon guidance (p = 1.66E-09), hormone metabolic processes (p = 1.13E-08), behavioral regulation (p = 8.86E-07), dopamine receptor signaling (p = 1.51E-06), cytokine secretion (p = 6.73E-06), and drug response (p = 1.17E-04; Supporting Information Table S1 ). As a control, we reran the GO analysis with a comparable number of randomly selected CpG sites and found only a chance-level overlap in identified terms (<5%).
| Region-level analysis
The Comb-p analysis identified two genome-wide significant regions (DMRs), both of which were annotated to the DRD4 gene. Consistent with the probe-level analysis above, these two regions were adjacent to one another (spanning a total of 603 bp) and encompassed the five DMPs listed in Table 1 -all of which were hypo-methylated in relation to physical aggression, following a dose-response gradient (see Sup- porting Information Figure S3 for scatterplots). The first region included probes cg03909863, cg01616529, and cg05717871 (chromosomal coordinates: start = 638,404, end = 638,507; Sidakcorrected regional p = 1.09E-07), whereas the second region included probes cg11335335 and cg07212818 (chromosomal coordinates: start = 637,885, end = 638,076; Sidak-corrected regional p = 1.62E-04). Overall, these five probes showed moderate-to-high intercorrelations (r = .47-.79), with 74% of shared variance between them explained by a single principal component (eigenvalue = 3.72, princomp function; see Supporting Information Figure S4 ). Importantly, results from Comb-p were confirmed using the DMRcate package, in which the same five probes formed the only DMR to survive genomewide correction (chromosomal coordinates: start = 637,885, end = 638,507; q = 6.61E-15, Stouffer-corrected p = .01). Consequently, these five probes were examined as a single region in subsequent analyses.
| Follow-up analyses: Characterizing DRD4 methylation
In light of the above findings, we carried out a number of follow-up analyses to better characterize patterns of DRD4 methylation in this sample.
Associations between the DRD4 DMR and correlates of physical aggression
First, we examined associations with known environmental and phenotypic correlates of physical aggression. (a) bivariate: r = −.39, p = 1.10E-05; (b) partial: r = −.28, p = .01; partial correlations for individual CpGs are also shown in Table 2 ). While this resulted in a considerable drop in effect size, the difference between the adjusted and nonadjusted correlation was not significant (Z = 1.06, p = .14).
Wider analysis of methylomic variation across the DRD4 gene (Zhu et al., 2013) . Second, we found that 90% (n = 19) of sites coincided with transcription factor binding sites (data generated from 91 cell-types)-DNA regions where one or more specific proteins responsible for regulating transcription bind to. This overlap was identified across multiple tissues spanning all three germ layers (i.e., endoderm, mesoderm, and ectoderm), with the strongest signal linked to the EZH2 transcription factor, a functional enzymatic component of the Polycomb complex PRC2
that is involved in transcriptional repression and early development (Margueron & Reinberg, 2011 Associations between methylomic variation in the DRD4 DMR and known correlates of physical aggression 
Sensitivity analyses
We carried out a set of sensitivity analyses to test the robustness of associations between DRD4 methylation and our measure of physical aggression. First, we winsorized DNAm data to reduce the influence of potential outliers (>3 SD) using the DescTools package with default settings. The winsorizing method uses censoring rather than exclusion, which is preferable with small sample sizes (Sheskin, 2003) . Second, we ran a surrogate variable analysis ( Table S3 for full results).
Saliva-blood concordance
Before proceeding to the replication step, we wanted to ensure that we could validly compare associations between DRD4 methylation and physical aggression across different peripheral tissues. This is because in our discovery sample, DNAm was drawn from buccal swabs, whereas in the replication sample it was extracted from blood (T cells). As we did not have access to multiple tissues in our discovery sample, we examined instead published data characterizing saliva-blood concordance for all Illumina 450k probes, based on matched samples from 64 adults . Of note, the Smith et al. study examined saliva, not buccal swabs.
However, these two DNA sources typically contain the same mixture of cell-types (i.e., buccal epithelial cells and leukocytes), although proportions of buccal epithelial cells tend to be higher in Table S4 ).
| Step 2. Replication in peripheral T cells in an independent sample
Given the above evidence for cross-tissue concordance, we proceeded to replicate our findings on DRD4 methylation in a different peripheral tissue (blood T cells) extracted from an independent sample of young adults following a low (LPA) versus chronic (CPA) trajectory of physical aggression from childhood to adolescence. Methylation values for one participant in the LPA group were winsorized due to presence of outliers (>3 SD), even though findings were consistent when using the original values. Descriptive statistics are presented in Table 3B , including means and standard deviations for each DRD4 site, percent methylation differences and associated effect sizes (Hedge's g, given the small sample size). To facilitate comparability with the replication sample-which used a case-control design-we include the same descriptive information for our discovery sample, split into two groups based on the binary fights variable (i.e., "No fights" vs. "Any fights").
The direction of associations was consistent across both samples, with lower DNAm associating with higher physical aggression.
On average (i.e., across all 21 probes annotated to DRD4), there was a 3.85% difference in DRD4 methylation between groups in our sample (range = 0.01-10.7%), compared to 3.06% in the replication sample (range = 0.20-8.14%). Effect sizes were typically modest in the discovery sample (mean g = −0.41) and large in the replication sample (mean g = −0.94). in table) . Two of these were located in our genome-wide DMR (cg03909863 and cg11335335), and three others were nominally significant in the discovery sample (cg06299284, cg06825142, and cg23501406).
As a more stringent test of replication, we created a polyepigenetic score (ePGS) of DRD4 methylation, following a method commonly used in molecular genetic studies and recently extended to epigenetic data (Shah et al., 2015) . Specifically, for each CpG site, we multiplied the methylation values from the replication sample by their respective standardized regression betas from the discovery sample (i.e., independent weights), and then summed these 
| Follow-up analysis: Relevance to the brain
Blood-CNS concordance in DRD4 methylation
The results from the replication analysis suggest that DNAm patterns in DRD4 may reliably associate with physical aggression across distinct peripheral tissues (buccal vs. blood T cells). Yet, the extent to which these markers may reflect DNAm patterns in the brain is unclear. To address this, we investigated peripheral-CNS concordance in DRD4 methylation, using published Illumina 450k data from two independent sources. The first consisted of data from over 70 individuals for whom matched DNA samples were isolated from both premortem whole blood and postmortem CNS tissue across four brain regions Table S2 ; for a visual example of associations with the top DRD4 probe cg07212818, see Supporting Information Figure S5 ).
In contrast, blood-CNS correspondence with at least one region was observed for only 1 of the 9 (11%) DRD4 sites that were not associated with physical fights. In line with the findings on saliva-blood correspondence presented above, we found that, overall, the strength of Information Table S2 , which also includes information on all other DRD4 probes). Overall, DRD4 probes showed high variability and strong cross-tissue concordance in this sample. Regions that were most comparable across resources (e.g., Hannon's prefrontal cortex and Edgar's BA10) also showed the strongest convergence in findings, which adds validity to the results (Supporting Information Table S4 ).
As with the other resources, the strength of associations with physical fights in our sample correlated with that of blood-brain correspondence in Edgar et al.'s sample (r = .55, p = .01). A graphical representation of BECon results showing blood-brain variability and correspondence for DRD4 sites contained in our DMR is provided in Supporting Information Figure S5 .
DRD4 expression in the brain
Given the above support for cross-tissue concordance in DRD4 methylation across saliva, blood, and brain, we investigated expression levels of DRD4 in CNS versus peripheral tissues using the GenotypeTissue Expression project portal (GTEx; http://www.gtexportal.org/ home/; The GTEx Consortium, 2015), which is based on data on 53 tissues from 544 donors. Expression levels across available brain regions as well as the three most relevant peripheral tissues to our study are graphically presented in Supporting Information Figure S5 , including:
(a) salivary gland, (b) esophagus mucosa, which comprises of squamous epithelial cells that are part of the same cell-type family as buccal epithelial cells, and (c) whole blood. Generally, DRD4 expression was low across all tissues, with the cerebellum showing the highest levels of expression in the brain. Other brain regions of relevance to physical aggression, including the frontal cortex, amygdala, and hippocampus showed similar levels of expression to the two peripheral tissues closest to buccal cells (i.e., salivary gland and esophagus mucosa), whereas whole blood showed the lowest expression levels.
| Step 3. Mendelian randomization analysis to test for causal pathways
As a final step, we investigated whether peripheral DRD4 methylation exerts a causal effect on physical aggression using MR analysis. Of the 12 DRD4 sites nominally associated with physical aggression in our discovery sample, 6 (50%) were linked with at least one mQTL, suggesting that DNAm levels across these CpG sites are likely to be under considerable genetic control (Supporting Information Table S2 ). One of these mQTLs (cis SNP rs2740373) was eligible to be used as a genetic instrument in the MR analysis, as it was the only polymorphism which was investigated for an association with physical aggression, based on data from a recently published GWAS by the EAGLE Consortium (Pappa et al., 2016 ; n = 18,832, p = .95). Of note, this mQTL was predictive of DNAm levels across three CpG sites, all of which were contained in the DMR (cg07212818, cg11335335, and cg01616529; Supporting Information Table S2 ). Consequently, we ran three MR analyses with the same genetic instrument-one for each of these CpG sites. Across all CpG sites, MR results were nonsignificant, meaning that a causal effect of peripheral DNAm on engagement in physical fights was not supported, even though the direction of effects was consistent with the findings from our discovery and replication analyses (i.e., negative association between DNAm and physical aggression; for full results see Supporting Information Figure S6 ).
| DISCUSSION
The overall aim of the present study was to characterize DNAm patterns associated with physical aggression, using a multisample, crosstissue design. We highlight here three key findings. First, we conducted an epigenome-wide analysis of physical aggression-measured as engagement in physical fights-based on buccal cell DNA drawn from a sample of high-risk youth. We found that lower DNAm levels in one region spanning the DRD4 gene survived genome-wide correction, was associated with higher physical aggression over and above co-occurring symptomatology, and showed strong cross-tissue concordance with both blood and brain tissue. Second, we replicated these findings in an independent sample of young adults based on DNA from a different peripheral tissue (blood T cells). Specifically, we found that DRD4 methylation levels significantly differentiated between adults with a chronic-high versus low history of physical aggression in childhood and adolescence. Third, using published GWAS data from the EAGLE consortium, we ran a MR analysis to test for a causal effect of peripheral DRD4 methylation on aggression.
Based on the only eligible genetic instrument, we did not find evidence to support causal effects. Overall, our findings point to peripheral DRD4 methylation as a potential biomarker of physical aggression, with no evidence yet supporting a causal association.
| The epigenetic signature of physical aggression in buccal cells
Recent data suggests that DNAm in buccal cells may be a useful tool for the investigation of brain-based phenotypes, as they are derived from the same ectodermal layer as brain cells during development, and have been shown to correlate with CNS methylation more strongly than other commonly examined peripheral tissues, such as blood . So far, published epigenetic studies on physical aggression in humans have all made use of blood samples Provençal, Suderman, Caramaschi, et al., 2013; Provençal et al., 2014; Wang, Szyf, et al., 2012) . Here, we performed the first genome-wide study characterizing DNAm patterns associated with physical aggression in buccal cells, using both probe-and regionlevel approaches. Of note, regional analyses are a useful complement to probe-level analyses, as they draw on the intercorrelated nature of DNAm data to alleviate multiple-testing burden, increase power to detect effects, and reduce the likelihood of false positives (Robinson et al., 2014) .
The key finding to emerge from our genome-wide analyses implicated epigenetic regulation of the Dopamine Receptor D4 (DRD4) gene-one of the most extensively studied candidate genes for aggression and related externalizing problems . Specifically, we identified one region in the gene body of DRD4 that associated with engagement in physical fights after genome-wide correction (using two separate methods). More broadly, over half of all sites annotated to DRD4 showed at least nominal associations, whereby individuals who showed lower DNAm levels in these sites reported more frequent engagement in physical fights. These associations were robust to sensitivity tests and not unduly driven by extreme scores in either the DNAm data or the physical fights outcome variable. Furthermore, GO analysis indicated significant enrichment for "dopamine receptor signaling," supporting the probe-and region-level results. Together, these data converge on DRD4 methylation as the most robust epigenetic signal associated with physical aggression.
Besides dopamine signaling, we identified enrichment of other biological processes relevant to aggression. One of these was "hormone metabolic processes," with several high-ranking DMPs annotated to thyroid hormone pathway genes (TRH, FDX1, TNX2, and TXNRD2), consistent with prior evidence of thyroid hormone dysregulation in pathological aggression in humans (Evrensel, Ünsalver, & Özşahin, 2016) and attack behavior in mice (Hrabovszky et al., 2005) .
Another set of enriched pathways related to inflammatory processes, including "cytokine secretion." This is in line with reported alterations in DNAm and expression levels of cytokine genes in individuals with a chronic history of childhood physical aggression (Provençal, Suderman, Caramaschi, et al., 2013; Provencal, Suderman, Vitaro, Szyf, & Tremblay, 2013) , as well as in individuals diagnosed with IED (Montalvo-Ortiz et al., 2018) . We also identified enrichment for multiple CNS-related processes, such as "Axon guidance." Interestingly, this same GO pathway was found to be highly enriched in the EWAS study on global aggression by van Dongen et al. (2015) as well as a recent bioinformatic analysis combining findings from six GWAS studies on aggression-related phenotypes . Finally, we observed enrichment for regulation of "behavior,"
which was again reported in the EWAS by van Dongen et al. (2015) in a general population of twins, but also in the EWAS by Guillemin et al. (2014) in adults following a chronic versus low trajectory of physical aggression in childhood. In summary, our findings point to an "epigenetic signature" of physical aggression in buccal cells that is enriched for numerous biological processes, spanning neural, hormonal, immune and behavioral domains.
| Findings support the involvement of DRD4 in aggressive behavior
Dopamine is widely considered to be a key player in the neurobiology of aggressive behavior (Hagenbeek et al., 2016) . Its uptake from the synaptic cleft is modulated by the dopamine receptor family, encoded by genes DRD1 through to DRD5. Of these, DRD4 has received the most attention for its potential role in aggression and related phenotypes (Pappa et al., 2016) . Specifically, genetic variants of DRD4 that confer lower expression have been associated with higher aggression, delinquency, and externalizing behavior in child and adult populations as well as elevated risk for psychiatric diagnoses that are often accompanied by high aggression (e.g., CD, ADHD, ASPD, schizophrenia, substance use disorders; Ptacek, Kuzelova, & Stefano, 2011) . Furthermore, DRD4 polymorphisms have been associated with temperamental and personality traits closely related to aggression, including sensation-seeking, risktaking, impulsivity, anger, and reward sensitivity (Munafò, Yalcin, Willis-Owen, & Flint, 2008) . The genetic literature on DRD4, however, has been far from consistent with several studies reporting null findings (see Pappa, Mileva-Seitz, Bakermans-Kranenburg, Tiemeier, & van IJzendoorn, 2015 , for a review). It has been suggested that, in addition to methodological differences, these inconsistencies may reflect moderation by the environment, as the dopamine system is known to be responsive to environmental inputs across development (Vassos, Collier, & Fazel, 2014) .
The present study supports and extends previous findings of a link between DRD4 and aggression at multiple biological levels, from genetics to physiology. Specifically, it is the first to show that this link is also observable at the epigenetic level, with lower levels of DRD4 methylation found to associate with greater physical aggression. Interestingly, we found that several sites in the DMR were strongly associated with known genetic mQTLs (Gaunt et al., 2016) as well as showing small associations with environmental exposures in our sample, including neighborhood disadvantage and CVE. While preliminary, these data are consistent with the hypothesis that DNAm patterns may reflect (and potentially mediate) the influence of genetic and environmental inputs on behavioral phenotypes (Uher, 2014) . Although no study has specifically examined DRD4 methylation in the context of aggressive behavior, several studies have reported an association with related phenotypesparticularly risk of ADHD (e.g., Dadds, Schollar-Root, Lenroot, Moul, & Hawes, 2016; van Mil et al., 2014) . The question therefore arises as to whether DNAm patterns in this gene may be specific to aggression, shared with-or even entirely confounded by-co-occurring symptomatology. To address this, we examined associations between the DRD4 DMR and common psychiatric and behavioral correlates of physical aggression. We found that, besides physical aggression, DNAm levels in this region were most strongly correlated with self-reported drug use, followed by informant-rated levels of (low) prosocial behavior, CU traits, and externalizing-but not internalizing-psychiatric symptoms (esp. CD and ASPD). Overall, these findings are consistent with genetic studies implicating DRD4 in externalizing psychiatric symptoms and substance use (Ptacek et al., 2011) , as well as CU and psychopathic traits (Yildirim & Derksen, 2015) . In part, these shared associations may reflect the role of dopamine signaling in processes that are common to multiple externalizing problems, such as sensation-seeking, impulsivity, and reward processing (Beauchaine & McNulty, 2013) . Importantly, however, the association between DRD4 methylation and physical aggression was not entirely explained by shared variance with other functional domains, remaining significant even after adjusting for all co-occurring symptomatology. Consequently, our findings suggest that while DRD4 methylation patterns may be shared across multiple forms of externalizing problems, they also show an independent association with physically aggressive behavior. In future, more work will be needed to identify what factors may be driving the shared versus unique associations observed between DRD4 methylation, physical aggression, and co-occurring externalizing symptoms. Furthermore, an important avenue for future research will be to test whether specificity of associations can be improved if DRD4 methylation is combined with other known risk factors for physical aggression (e.g., across psychosocial, demographic, and contextual domains), and conversely, whether the inclusion of DRD4 methylation in predictive models for physical aggression can result in greater predictive power and classification accuracy above the use of traditional risk factors alone.
| DRD4 methylation as a potential cross-tissue biomarker of physical aggression
Having established a robust link between DRD4 methylation and physical aggression in buccal cells, we proceeded to test the degree to which these patterns may also be observed in other peripheral and central tissues. We found that for over 80% of DRD4 sites that were at least nominally associated with physical aggression in our sample (including all sites in the DMR region), DNAm levels in saliva significantly associated levels in blood. Our findings are consistent with previous reports of saliva-blood concordance in DRD4 methylation, including a recent study documenting comparable associations between DNAm levels and ADHD risk in these two peripheral tissues (Dadds et al., 2016) .
Given evidence of strong concordance, our next aim was to replicate the DRD4-aggression findings in blood, using the same sample upon which most of the epigenetic studies of physical aggression to date have been based Provençal, Suderman, Caramaschi, et al., 2013; Provençal et al., 2014; Wang, Szyf, et al., 2012) . Both samples were found to show consistency in the direction of associations with physical aggression (i.e., lower DNAm = higher physical aggression) as well as in the average DRD4 methylation difference between groups (>3%). Furthermore, effect sizes were typically modest in the discovery sample (average g = −0.41) and large in the replication sample (average g = −0.94), which may reflect more precise phenotyping in the latter (i.e., discovery sample: self-reported item indexing engagement in fights in the past year; replication samples: trajectories of informant-rated physical aggression based on repeated longitudinal assessments). In the replication sample, we found that 38% of probes annotated to DRD4 were differentially methylated between the CPA and LPA group (compared to 57% in the discovery sample), including two sites located in our genome-wide DMP. As a more stringent test of replication, we built a polyepigenetic score (ePGS), where DRD4 methylation levels from the replication sample were weighted by the (independent) effect sizes from the discovery sample, and found that this ePGS score was also differentially methylated between groups.
The above findings suggest that DNAm patterns in DRD4 are comparable between buccal cells and blood, and reliably associate with physical aggression across these distinct peripheral tissues. Yet, based on this data alone, it is not possible to establish whether crosstissue concordance extends to the brain-likely the most relevant organ for the study of aggression. To test this, we examined peripheral-CNS correlations in DRD4 methylation, based on two independent data sources of matched premortem whole blood and postmortem brain tissue across (Edgar et al., 2017; Hannon et al., 2015) .
Similar to the saliva-blood findings, we found that the vast majority of DRD4 sites at least nominally associated with engagement in physical fights showed significant peripheral-CNS concordance across both resources, including all sites in our DMR. These findings are in line with data showing high concordance in DRD4 methylation patterns between blood and brain tissue in humans (Docherty et al., 2012) as well as in animals selectively bred for high versus low exploratory behavior (Verhulst et al., 2016) . Interestingly, we found that physical aggression-related DRD4 sites showed stronger peripheral-CNS convergence in frontotemporal regions compared to the cerebellum.
However, it is important to note that we were not able to test whether DRD4 methylation levels in the brain also associate with physical aggression, which will require access to postmortem samples with recorded histories on this behavioral phenotype.
Overall, the strong cross-tissue concordance in DRD4 methylation observed in our study suggests that methylation status of this gene in easily accessible peripheral tissues, such as buccal cells and blood, may have utility as a valid proxy of methylation status in the brain.
Furthermore, the robustness and reproducibility of our findings across independent samples and tissues points to DRD4 methylation as a potential biomarker for physical aggression, in line with the broad definition of a biomarker (Biomarkers Definitions Working Group, 2001 ).
This, however, represents only the first step in a longer process of biomarker discovery and validation. In particular, it will be important to systematically evaluate the accuracy (i.e., sensitivity and specificity) of DRD4 methylation as a biomarker for physical aggression, to inform its potential translational applications.
| Probing causal pathways using Mendelian randomization
Up to this point, our findings support DRD4 methylation as a potential cross-tissue biomarker for physical aggression, with strong concordance observed across buccal cells/saliva, blood, and brain. Yet, this alone does not necessarily imply that DRD4 methylation plays a mechanistic role in physically aggressive behavior. In other words, a biomarker can be reliably associated with a phenotype of interest, without being causally related to it. Differentiating between causal and noncausal biomarkers is crucial for informing which translational application may be most appropriate (e.g., noncausal biomarker = use in detection, management and monitoring of symptoms; causal biomarker = potential target for prevention and treatment strategies).
Based on functional studies on DRD4, DNAm levels in the gene body (i.e., where our DMR was located) have been found to positively associate with DRD4 gene expression (i.e., higher DNAm relating to higher gene expression; Cheng et al., 2014) . Thus, the association between DNAm and physical aggression observed in the present study could be interpreted as indicating that: (a) lower gene body methylation is linked with lower DRD4 expression; which in turn (b) relates to a lower density of DRD4 receptors and decreased dopamine binding potential; thereby (c) associating with higher physically aggressive behavior.
Consistent with this, one study found that children with ADHD had lower concentrations of DRD4-mRNA in whole blood compared to a control group (Taurines et al., 2011) . Furthermore, lower binding potential of D2-like dopamine receptors has been associated with a range of negative outcomes, including substance use and addiction (Martinez et al., 2007 ).
Here, we tested for a causal effect of DRD4 methylation on physical aggression using MR analysis (Relton & Davey Smith, 2012) . We found that only one of the SNPs identified as mQTLs for DRD4 methylation in our sample had the necessary characteristics to be used as a genetic instrument in the MR analysis (i.e., the only one with available GWAS data on aggression; Pappa et al., 2016) . Using this single SNP, we did not find evidence to support a causal association between peripheral DRD4 methylation and physical aggression, even though the direction of effects was consistent with our data (i.e., lower DNAm = higher aggression). If confirmed in future studies, these findings would suggest that peripheral DRD4 methylation patterns may have greater utility as a noncausal biomarker of physical aggression rather than an intervention (i.e., modifiable) target for strategies aiming to reduce aggressive behavior. However, it is important to note that given the reliance on a single SNP, our findings do not preclude entirely the possibility of causal effects, and as such should not be interpreted as conclusive evidence for lack of causality. Furthermore, it is possible that, rather than exerting causal effects per se, peripheral DRD4 methylation patterns reflect DNAm status in the brain, where causal effects on physical aggression are exerted. To evaluate this possibility, future MR studies should aim to select as genetic instruments only SNPs that reliably associate with DRD4 methylation patterns in both peripheral and brain tissue, which we were not able to ascertain in our study. Finally, the analysis had a number of additional limitations (see below), so that findings should be considered preliminary, until more-powered and comprehensive MR studies are conducted testing this association.
| Limitations and future directions
The present findings should be interpreted in light of several limitations. First, our discovery and replication samples were relatively small. Although both samples were at high-risk of psychiatric symptomatology and showed variability in physically aggressive behavior-thus increasing power to detect effects-more work will be needed to replicate findings in larger populations. Of note, no sex differences in physical aggression were identified in our sample, which is consistent with prior research reporting less pronounced sex differences in aggression within high-risk youth (Connor, 2012) . Second, our genome-wide analysis was based on one self-reported item indexing engagement in physical fights over the past year. From this item, it was not possible to ascertain whether participants had actually initiated the fight or not. However, the fact that this measure associated with informant-rated psychiatric and behavioral correlates of physical aggression in the expected direction, and that DRD4 findings replicated in an independent sample of individuals with well-characterized histories of physical aggression adds confidence to the present results.
Third, although we identified significant convergence in aggression-related DRD4 methylation patterns across peripheral and CNS tissues, associations with aggression were only verified in buccal cells and blood. Consequently, it will be important to replicate our findings in the brain, for example by using postmortem samples (Bakulski et al., 2016) and imaging epigenetic strategies in live humans (Nikolova & Hariri, 2015; Walton et al., 2017) . Bearing this in mind, the strong cross-tissue convergence in DRD4 methylation levels observed across tissues from different germ layers (ectoderm: buccal epithelial cells and brain; mesoderm: blood) is notable. Future studies should investigate whether this concordance may be driven by genetic effects-as supported by the large number of mQTLs associated with our DRD4 loci-and/or driven by stochastic and environmental effects occurring during early embryonic development, as in the case of metastable epialleles (Rakyan, Blewitt, Druker, Preis, & Whitelaw, 2002) .
Indeed, when cross-checking our five DMR sites with a recently published list of potential metastable epialleles (Van Baak et al., 2018) , we found that none of the mQTL-associated sites were included the list, but conversely that one of the sites not associated with mQTLs (cg03909863) was listed as a candidate metastable epiallele. On a broader level, more work will be needed to characterize the crosstissue properties of mQTLs and expression patterns associated with our aggression-related DRD4 loci.
Fourth, data on smoking status and medication use were not available in the present study. In addition, our measures of substance use did not enable us to capture important characteristics, such as type, history, and quantity of substance use, all of which may influence DNAm patterns. While we applied multiple strategies to minimize the possibility of residual confounding (e.g., SVA, independent replication, etc.), future studies are needed to confirm our findings controlling for these potential confounders. It is noteworthy, however, that none of the DNAm sites identified in the present study overlapped with those found to be robustly affected by smoking in a recent systematic review (Gao, Jia, Zhang, Breitling, & Brenner, 2015) .
Fifth, we only focused on DRD4 methylation following our epigenome-wide analyses, given that this gene was identified using both probe-and region-level approaches, as well as converging with prior evidence from molecular genetic research implicating DRD4 in aggression. Nevertheless, our epigenome-wide analysis identified a number of additional DNAm sites of interest, which deserve further investigation in future.
Finally, although MR findings did not support a causal association of peripheral DRD4 methylation with physical aggression, it is important to note that analyses were based on the single, currently usable genetic instrument (rather than focusing on all SNPs implicated in our analyses), and may have therefore been underpowered to detect what are likely to be small effects. Furthermore, GWAS data for the analysis was extracted from a study investigating global aggression (Pappa et al., 2016) , as opposed to physical aggression per se, which denotes a particularly severe aggression phenotype (Tremblay, 2000) . In future, studies should aim to use genetic instruments from larger samples and derived from multiple SNPs, which explain greater variance in DNAm. It will also be of interest to apply a two-way MR to examine the possibility of reverse causation-that is, whether greater physical aggression leads to lower DRD4 methylation. This approach should be complemented with prospective, longitudinal studies featuring repeated measures of DRD4 methylation and physical aggression, to further disentangle the directionality of associations within a transactional framework. To systematically evaluate causality in the relationship between DRD4 methylation and physical aggression, it will also be necessary to triangulate findings from MR with those of other causal inference approaches, such as genetically-informative twin studies and animal experimental models (Pingault et al., 2018) .
Together, future work addressing these research gaps will mark an important step toward characterizing more precisely the potential translational utility of DRD4 methylation in the detection, prevention, and management of physically aggressive behavior.
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